Today-Apr 12

A French multinational pharmaceutical company said on Monday (April 12) that it will be investing €400 million (about S$638 million) over the next five years to create a fully digital vaccine production facility in Singapore capable of manufacturing several vaccine types simultaneously.  The Tuas South facility, the first of its kind in Asia, is a collaboration between the Economic Development Board (EDB) and pharmaceutical heavyweight Sanofi.  The site will mainly supply the Asian region and complement existing manufacturing capabilities in Europe and North America. When it goes operational in the first quarter of 2026, it is also expected to create about 200 jobs in Singapore, including some in the areas of quality control and assurance, as well as logistics.

Read more at https://www.todayonline.com/singapore/french-firm-sanofi-invests-s638-million-build-vaccine-production-facility-tuas-south